Endoscopic retrograde cholangiopancreatography (ERCP) is an endoscopic technique in which a specialized side-viewing upper endoscope is guided into the duodenum, the bile and pancreatic ducts are opacified by injection of a contrast medium, and allowing for a variety of therapeutic interventions . Patients with cirrhosis can tolerate ERCP to treat their biliary tract or pancreatic diseases. Patients with liver cirrhosis are 3 times more susceptible to cholelithiasis, than the non-cirrhotic population plus the biliary and pancreatic cancer and other disease. Child—Pugh classification is the determinative factor of ERCP treatment and the most important predictor of outcome in these patients. The main severe complication post— ERCP is bleeding .